111
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Gammabutyrolactone: withdrawal syndrome resembling delirium tremens

&
Pages 384-387 | Published online: 03 Oct 2011

References

  • Church, R. (1999). Gamma hydroxybutyrate, the substance abuse monitor (pp. 1–5). Little Rock, AR: SAM Press.
  • Dyer, J. E. (1999). Gamma hydroxybutyrate. In K. R. Olson (Ed.), Poisoning and drug overdose (3rd ed., pp. 197–180). San Francisco, CA: Appleton and Lange.
  • Fadda, F., Colombo, G., Mosca, E., & Gian Luigi Gessa, G. L. (1989). Suppression by gamma-hydroxybutyric acid of ethanol withdrawal syndrome in rats. Alcohol and Alcoholism, 24, 447–451.
  • Gallimberti, L., Gentile, N., Cibin, M., Fadda, F., Canton, G., Ferri, M., Ferrara, S. D., & Gessa, G. L. (1989). Gamma hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet, II, 787–789.
  • Hernandez, M. (1998). GHB-induced delirium: A case report and review of the literature of gamma hydroxybutyric acid. American Journal of Drug and Alcohol Abuse, 24, 179–183.
  • Hoes, M. J. A. J. M., Vree, T. B., & Guelen, P. J. M. (1980). Gamma-hydroxy-butyric acid as hypnotic. L’Encephale, VI, 93–99.
  • Miotto, K., Darakjian, J., Basch, J. A., Murray, S., Jennifer Zogg, J., & Rawson, R. (2001). Gamma-hydroxybutyric acid: Patterns of use, effects and withdrawal. American Journal on Addictions, 10(3), 232–241.
  • Muller, A. A. (2003). GHB poisoning: Three recent cases reflect the continuing danger. Journal of Emergency Nursing, 29, 72–74.
  • Palatini, P., Tedeschi, L., Frison, G., Padrini, G. R., Zordan, R., Orlando, R., Gallimberti, L., Gessa, G. L., & Ferrara, S. D. (1993). Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. European Journal of Clinical Pharmacology, 45, 353–356.
  • Price, G. (2000). In-patient detoxification after GHB dependence. The British Journal of Psychiatry, 177, 181–182.
  • Roth, R. H., & Giarman, N. J. (1970). Natural occurrence of gamma-hydroxybutyrate in mammalian brain. Biochemical Pharmacology, 19, 1087–1093.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.